Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant.

Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. Abstract Text:

    ryan h senaratneRyan H Senaratne,joseph d mougousJoseph D Mougous,j rachel readerJ Rachel Reader,spencer j williamsSpencer J Williams,tianjiao zhangTianjiao Zhang,carolyn r bertozziCarolyn R Bertozzi,lee w rileyLee W Riley,

    The emergence of drug-resistant Mycobacterium tuberculosis strains and the widespread occurrence of AIDS demand newer and more efficient control of tuberculosis. The protective efficacy of the current Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine is highly variable. Therefore, development of an effective new vaccine has gained momentum in recent years. Recently, several M. tuberculosis mutants were tested as potential vaccine candidates in the mouse model of tuberculosis. However, only some of these mutants were able to generate protection equivalent to that of BCG in mice. This study reports the vaccine potential of an attenuated 5'-adenosine phosphosulfate reductase mutant (DeltacysH) of M. tuberculosis. Immunization of mice with either BCG or DeltacysH followed by infection with the virulent M. tuberculosis Erdman strain demonstrated that DeltacysH can generate protection equivalent to that of the BCG vaccine.

    Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. Publishing Authors By Initials

    rh senaratneRH Senaratne,jd mougousJD Mougous,jr readerJR Reader,sj williamsSJ Williams,t zhangT Zhang,cr bertozziCR Bertozzi,lw rileyLW Riley,

    For similar complex mixtures: biological products: vaccines: vaccines, attenuated research abstracts see: complex mixtures: biological products: vaccines: vaccines, attenuated research

    PUBMED ID PMID:

    MEDLINE DATE:

    Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Journal of medical microbiology

    VOLUME: 56

    Page Numbers: 454-8

    Journal Abbreviation: J. Med. Microbiol.

    ISSN: 0022-2615

    DAY: 3

    MONTH: Apr

    YEAR: 2007

    Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 224131

    Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. Keywords Mesh Terms:

    KEYWORDS: Vaccines, Attenuated

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. Information

    Substance Name: Vaccines, Attenuated

    Registry Number: 0

    Grant and Affiliation Information for Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant.

    AFFILIATION: School of Public Health, University of California, Berkeley, CA 94720, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIAID

    GRANT: AI-51622

    ACRONYM: AI

    MEDLINETA: J Med Microbiol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News